Highly Efficient Stereocontrolled Synthesis of
Danishefsky’s Taxol CD Ring Key Intermediate
Paul Brémond, Ge´rard Audran,* and Honore´ Monti
UniVersite´ Paul Ce´zanne, Institut des Sciences Mole´culaires
de Marseille (ISM2), UMR-CNRS-6263, Equipe STe´Re´O
Campus Scientifique de Saint-Je´roˆme, Case 541
13397 Marseille Cedex 20, France
FIGURE 1. Structures of baccatin III, taxol, and taxotere.
framework of taxol have attracted the attention of biologists,
medicinal chemists, and synthetic chemists.
g.audran@uniV-cezanne.fr
ReceiVed April 28, 2008
The synthesis of taxol has presented one of the more difficult
challenges to synthetic chemists, both because of its complex
ring structure and because of its numerous chiral centers. As a
consequence, tremendous efforts toward its synthesis have been
made, which have so far resulted in six successful total syntheses
of this molecule.8–14 Among them, the elegant Danishefsky
group synthesis9 is the only one to start with a preformed CD
ring system (+)-1 (Scheme 1). This pivotal intermediate was
coupled with an A ring synthon to afford the A-CD unit, and
cyclization to the ABCD system was achieved by the Heck
reaction. Subsequent appropriate oxidative chemistry and func-
tional group manipulations led to baccatin III and taxol. The
key to the success of this strategy was the discerning choice of
protecting groups able to resist further chemical steps on the
CD ring unit. Particularly, the protection of the C4 tertiary
hydroxyl center as a benzyl ether rather than as an acetate, thus
avoiding complications from neighboring group participation
by this group later, was crucial (Scheme 2).
Danishefsky’s taxol CD ring key intermediate is synthesized
in 15 steps and 11.4% overall yield from a readily available
starting material. Absolute stereochemistry of the starting
material and stereocontrolled steps determine the absolute
configuration of the five requisite contiguous stereocenters.
(5) Rowinsky, E. K.; Cazenave, L. A.; Donehower, R. C. Nat. Cancer Inst.
1990, 82, 1247–1259.
The tetracyclic diterpenoid paclitaxel (Taxol, Figure 1),1
originally isolated from the Pacific yew tree Taxus breVifolia,2
is a powerful therapeutic drug for cancer chemotherapy.3
Particularly, this molecule and its synthetic analogue docetaxel
(Taxotere, Figure 1)4 exhibit strong antitumor activity against
ovarian and breast cancers,5,6 and additional exciting clinical
uses are anticipated.3c,7 Over the past two decades, important
biological activity, limited supplies, and unique structural
(6) McGuire, W. P.; Rowinsky, E. K.; Rosenhein, N. B.; Grumbine, F. C.;
Ettinger, D. S.; Armstrong, D. K.; Donehower, R. C. Ann. Intern. Med. 1989,
111, 273–279.
(7) (a) Rowinsky, E. K.; Donehower, R. C. Engl. J. Med. 1995, 332, 1004–
1014. (b) Ojima, I.; Bounaud, P.; Ahern, D. G. Bioorg. Med. Chem. Lett. 1999,
9, 1189–1194. (c) Fang, W. S.; Liang, X. T. Mini-ReV. Med. Chem. 2005, 5,
1–12. (d) Galletti, E.; Magnani, M.; Renzulli, M. L.; Botta, M. ChemMedChem
2007, 2, 920–942. (e) Kingston, D. G. I. Phytochemistry 2007, 68, 1844–1854.
(8) (a) Nicolaou, K. C.; Yang, Z.; Liu, J. J.; Ueno, H.; Nantermet, P. G.;
Guy, R. K.; Claiborne, C. F.; Renaud, J.; Couladouros, E. A.; Paulvannan, K.;
Sorensen, E. J. Nature 1994, 367, 630–634. (b) Nicolaou, K. C.; Ueno, H.; Liu,
J.-J.; Nantermet, P. G.; Yang, Z.; Renaud, J.; Paulvannan, K.; Chadha, R. J. Am.
Chem. Soc. 1995, 117, 653–659.
(1) Taxol is the registered trademark of Bristol-Myers Squibb Company for
paclitaxel.
(2) Wani, M. C.; Taylor, H. L.; Wall, M. E.; Coggnon, P.; McPhail, A. T.
J. Am. Chem. Soc. 1971, 93, 2325–2327.
(9) (a) Masters, J. J.; Link, J. T.; Snyder, L. B.; Young, W. B.; Danishefsky,
S. J. Angew. Chem., Int. Ed. Engl. 1995, 34, 1723–1726. (b) Danishefsky, S. J.;
Masters, J. J.; Young, W. B.; Link, J. T.; Snyder, L. B.; Magee, T. V.; Jung,
D. K.; Isaacs, R. C. A.; Bornmann, W. G.; Alaimo, C. A.; Coburn, C. A.; Di
Grandi, M. J. J. Am. Chem. Soc. 1996, 118, 2843–2859.
(3) General reviews on taxoid chemistry: (a) Gue´nard, D.; Gueritte-Voegelein,
F.; Lavelle, F. Curr. Pharm. Des. 1995, 1, 95–112. (b) Holmes, F. A.; Kudelka,
A. P.; Kavanagh, J. J.; Huber, M. H.; Ajani, J. A.; Valero, V. In Taxane
Anticancer Agents: Basic Science and Current Status; Georg, G. I., ; Chen, T. T.,
; Osima, I., ; VyasD. M., Eds.; ACS Symposium Series 583; American Chemical
Society: Washington, DC, 1995; p 31. (c) Arbuck, S. G.; BlaylockB. A. In Taxol:
Science and Applications; SuffnessM., Ed.; CRC Press: Boca Raton, FL, 1995;
p 379. (d) The Chemistry and Pharmacology of Taxol and its DeriVatiVes; Farina,
V., Ed.; Elsevier: Amsterdam, 1995. (e) Kingston, D. G. I.; Yuan, H.; Jagtap,
P. J.; Samala, I. In Progress in the Chemistry of Organic Natural Products;
Herz, W., ; Kirby, G. W., ; Moore, R. E., ; Steglich, W., Eds.; Springer-Verlag:
Vienna and New York, 2002; Vol. 84. (f) Taxus: The Genus Taxus; Itokawa,
H., ; LeeK.-H., Eds.; Taylor & Francis: London and New York, 2003.
(4) Taxotere is the registered trademark of Sanofi Aventis (Rhoˆne-Poulenc
Rorer Company) for docetaxel. (a) Mangatal, L.; Adeline, M. T.; Gue´nard, D.;
Gueritte-Voegelein, F.; Potier, P. Tetrahedron 1989, 45, 4177–4190. (b) Gueritte-
Voegelein, F.; Gue´nard, D.; Mangatal, L.; Potier, P.; Guilhem, J.; Cesario, M.;
Pascard, C. Acta Crystallogr. 1990, C46, 781–784. Review: (c) Gue´nard, D.;
Gueritte-Voegelein, F.; Potier, P. Acc. Chem. Res. 1993, 26, 160–167.
(10) Holton, R. A.; Somoza, C.; Kim, H.-B.; Liang, F.; Biediger, R. J.;
Boatman, P. D.; Shindo, M.; Smith, C. C.; Kim, S.; Nadizadeh, H.; Suzuki, Y.;
Tao, C.; Vu, P.; Tang, S.; Zhang, P.; Murthi, K. K.; Gentile, L. N.; Liu, J. H.
J. Am. Chem. Soc. 1994, 116, 1597-1598; 1599-1600.
(11) Wender, P. A.; Badham, N. F.; Conway, S. P.; Floreancig, P. E.; Glass,
T. E.; Houze, J. B.; Crauss, N. E.; Lee, D.; Marquess, D. G.; McGrane, P. L.;
Meng, W.; Natchus, M. G.; Shuker, A. J.; Sutton, J. C.; Taylor, R. E. J. Am.
Chem. Soc. 1997, 119, 2757–2758.
(12) Mukaiyama, T.; Chiina, I.; Iwadare, H.; Saitoh, M.; Nishimura, T.;
Ohkawa, N.; Sakoh, H.; Nishimura, K.; Tani, Y.-I.; Hasegawa, M.; Yamada,
K.; Saitoh, K. Chem.—Eur. J. 1999, 5, 121–161.
(13) (a) Morihira, K.; Hara, R.; Kawahara, S.; Nishimori, T.; Nakamura, N.;
Kusama, H.; Kuwajima, I. J. Am. Chem. Soc. 1998, 120, 12980–12981. (b)
Kusama, H.; Hara, R.; Kawahara, S.; Nishimori, T.; Kashima, H.; Nakamura,
N.; Morihira, K.; Kuwajima, I. J. Am. Chem. Soc. 2000, 122, 3811–3820.
(14) Formal racemic synthesis of taxol: (a) Doi, T.; Fuse, S.; Miyamoto, S.;
Nakai, K.; Sasuga, D.; Takahashi, T. Chem. Asian J. 2006, 1, 370–383.
10.1021/jo800913x CCC: $40.75
Published on Web 06/18/2008
2008 American Chemical Society
J. Org. Chem. 2008, 73, 6033–6036 6033